Alghisi F et al. |
Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis. |
2011 |
Thorax |
pmid:21228426
|
Decaro N et al. |
Immunogenicity and protective efficacy in dogs of an MF59â„¢-adjuvanted vaccine against recombinant canine/porcine coronavirus. |
2011 |
Vaccine |
pmid:21272607
|
Arias JL et al. |
Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. |
2011 |
ACS Nano |
pmid:21275408
|
van den Brand JM et al. |
Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets. |
2011 |
J. Virol. |
pmid:21209108
|
Calabro S et al. |
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. |
2011 |
Vaccine |
pmid:21215831
|
Javelle E et al. |
Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine. |
2011 |
Vaccine |
pmid:21172376
|
Montagnani S et al. |
Autoimmune hemolytic anemia following MF59-adjuvanted influenza vaccine administration: a report of two cases. |
2011 |
Ann Pharmacother |
pmid:21189364
|
Bernstein DI |
Vaccines for cytomegalovirus. |
2011 |
Infect Disord Drug Targets |
pmid:22309618
|
Niehaus TD et al. |
Identification of unique mechanisms for triterpene biosynthesis in Botryococcus braunii. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21746901
|
Cheong HJ et al. |
Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. |
2011 |
Clin. Vaccine Immunol. |
pmid:21715575
|
Soto G et al. |
Acetoacetyl-CoA thiolase regulates the mevalonate pathway during abiotic stress adaptation. |
2011 |
J. Exp. Bot. |
pmid:21908473
|
Meyer K et al. |
A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection. |
2011 |
PLoS ONE |
pmid:21887300
|
Broeders NE et al. |
Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. |
2011 |
Clin J Am Soc Nephrol |
pmid:21921153
|
Achiraman S et al. |
Increased squalene concentrations in the clitoral gland during the estrous cycle in rats: an estrus-indicating scent mark? |
2011 |
Theriogenology |
pmid:21924481
|
Brito LA et al. |
An alternative renewable source of squalene for use in emulsion adjuvants. |
2011 |
Vaccine |
pmid:21723355
|
Weyermann C et al. |
Initial results on the composition of fingerprints and its evolution as a function of time by GC/MS analysis. |
2011 |
J. Forensic Sci. |
pmid:20707835
|
Parretta E et al. |
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. |
2011 |
Vaccine |
pmid:21406267
|
Ambike A et al. |
Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. |
2011 |
Langmuir |
pmid:21413743
|
Gao J et al. |
Laser-induced acoustic desorption/atmospheric pressure chemical ionization mass spectrometry. |
2011 |
J. Am. Soc. Mass Spectrom. |
pmid:21472571
|
Weschler CJ et al. |
Squalene and cholesterol in dust from danish homes and daycare centers. |
2011 |
Environ. Sci. Technol. |
pmid:21476540
|
Cauda V et al. |
"Liquid-phase calcination" of colloidal mesoporous silica nanoparticles in high-boiling solvents. |
2011 |
J. Am. Chem. Soc. |
pmid:21480591
|
Griffiths PD et al. |
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. |
2011 |
Lancet |
pmid:21481708
|
Liu CL et al. |
The direct observation of secondary radical chain chemistry in the heterogeneous reaction of chlorine atoms with submicron squalane droplets. |
2011 |
Phys Chem Chem Phys |
pmid:21455529
|
Inagaki YS et al. |
Investigation of the potential for triterpene synthesis in rice through genome mining and metabolic engineering. |
2011 |
New Phytol. |
pmid:21501172
|
Montana M et al. |
Safety review: squalene and thimerosal in vaccines. |
2010 Nov-Dec |
Therapie |
pmid:21176760
|
Smentek L and Hess BA |
Compelling computational evidence for the concerted cyclization of the ABC rings of hopene from protonated squalene. |
2010 |
J. Am. Chem. Soc. |
pmid:21080653
|
Fragapane E et al. |
A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. |
2010 |
Clin. Vaccine Immunol. |
pmid:20810680
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major. |
2010 |
Vaccine |
pmid:20888873
|
Khurana S et al. |
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. |
2010 |
Sci Transl Med |
pmid:20371470
|
Lippi G et al. |
Vaccination, squalene and anti-squalene antibodies: facts or fiction? |
2010 |
Eur. J. Intern. Med. |
pmid:20206873
|
Barnett SW et al. |
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. |
2010 |
J. Virol. |
pmid:20392857
|
Gylling H et al. |
Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study. |
2010 |
J. Lipid Res. |
pmid:20436182
|
Chen G et al. |
Optimization of nitrogen source for enhanced production of squalene from thraustochytrid Aurantiochytrium sp. |
2010 |
N Biotechnol |
pmid:20412873
|
Xiao L et al. |
The effect of squalane-dissolved fullerene-C60 on adipogenesis-accompanied oxidative stress and macrophage activation in a preadipocyte-monocyte co-culture system. |
2010 |
Biomaterials |
pmid:20488530
|
Carmona A et al. |
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. |
2010 |
Vaccine |
pmid:20600478
|
Caligiani A et al. |
Characterization of a potential nutraceutical ingredient: pomegranate (Punica granatum L.) seed oil unsaponifiable fraction. |
2010 |
Plant Foods Hum Nutr |
pmid:20607413
|
Zhao RY et al. |
Cloning and characterization of squalene synthase gene from Fusarium fujikuroi (Saw.) Wr. |
2010 |
J. Ind. Microbiol. Biotechnol. |
pmid:20585832
|
Yasuda Y et al. |
Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. |
2010 |
Adv Ther |
pmid:20586002
|
Frey SE et al. |
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. |
2010 |
Vaccine |
pmid:20619382
|
Dosio F et al. |
Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation. |
2010 |
Bioconjug. Chem. |
pmid:20597546
|
Sarpietro MG et al. |
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface. |
2010 |
Int J Pharm |
pmid:20635474
|
Sere YY et al. |
A Saccharomyces cerevisiae strain unable to store neutral lipids is tolerant to oxidative stress induced by α-synuclein. |
2010 |
Free Radic. Biol. Med. |
pmid:20850523
|
Bate J et al. |
Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. |
2010 |
Clin. Infect. Dis. |
pmid:21067352
|
Madhun AS et al. |
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. |
2010 |
Vaccine |
pmid:21034828
|
Kato S et al. |
Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. |
2010 |
J Nanosci Nanotechnol |
pmid:21137794
|
Lin FY et al. |
Mechanism of action and inhibition of dehydrosqualene synthase. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21098670
|
Ali NA et al. |
Essential oil composition of leaves of Stachys yemenensis obtained by supercritical COâ‚‚. |
2010 |
Nat. Prod. Res. |
pmid:21104527
|
Walker WT and Faust SN |
Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine. |
2010 |
Expert Rev Vaccines |
pmid:21105775
|
El Sahly H |
MF59™ as a vaccine adjuvant: a review of safety and immunogenicity. |
2010 |
Expert Rev Vaccines |
pmid:20923265
|
Waddington C et al. |
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. |
2010 |
Health Technol Assess |
pmid:20923610
|